RxDoctor Payments Data

Stephen Hicks, DO

Family Medicine · Birmingham, ALNPI 1700366408

Payments from drug & device makers

$6,134in general payments, 2019–2025

Across 374 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$860
  • Novo Nordisk$720
  • Lilly USA, LLC$564
  • AbbVie$422
  • Abbott$380
  • Bayer$378
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$6,134100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,134 in reported general payments places this provider in the 85th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$48,268
Medicare patients
159
Services billed
1,770

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide76$82,085
EliquisApixaban84$74,366
JardianceEmpagliflozin35$39,098
MounjaroTirzepatide24$28,569
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$23,680
LinzessLinaclotide30$23,168
TrulicityDulaglutide22$22,638
JanuviaSitagliptin Phosphate14$17,486
XareltoRivaroxaban11$17,243
MyrbetriqMirabegron22$15,032
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$10,787
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,866
Atorvastatin Calcium346$4,498
Pravastatin Sodium223$3,994
Losartan Potassium247$3,162

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$720$82,08576 claims
PfizerEliquis$860$74,36684 claims
Lilly USA, LLCMounjaro, Trulicity$564$51,20746 claims
Boehringer IngelheimJardiance$242$39,09835 claims
AbbVieLinzess, Synthroid$422$25,66056 claims
GSKAnoro Ellipta, Trelegy Ellipta$321$19,65334 claims
MerckJanuvia$47$17,48614 claims
Johnson & JohnsonXarelto$77$17,24311 claims
Astellas Pharma US IncMyrbetriq$39$15,03222 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →